Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
154M
-
Number of holders
-
50
-
Total 13F shares, excl. options
-
20.4M
-
Shares change
-
+10.9M
-
Total reported value, excl. options
-
$266M
-
Value change
-
+$142M
-
Number of buys
-
35
-
Number of sells
-
-12
-
Price
-
$13.08
Significant Holders of Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) as of Q1 2021
54 filings reported holding ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 as of Q1 2021.
Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) has 50 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.4M shares
of 154M outstanding shares and own 13.23% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (7.23M shares), Avidity Partners Management LP (2.23M shares), Abingworth LLP (1.62M shares), Consonance Capital Management LP (1.22M shares), Point72 Asset Management, L.P. (1.05M shares), VR Adviser, LLC (1M shares), VANGUARD GROUP INC (808K shares), Johnson & Johnson Innovation - JJDC, Inc. (729K shares), BlackRock Inc. (490K shares), and ADAGE CAPITAL PARTNERS GP, L.L.C. (488K shares).
This table shows the top 50 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.